Public Calendar: August 6-12, 2023
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
Event Date: 08/08/2023
Location: Virtual
Subject: Oncologic Drug Shortages
FDA Participant/Group: ANDREW ZACHER; JULIA TIERNEY;
Non FDA Participant/Group: Leslie Busby (Rocky Mountain Cancer Center);
Event Date: 08/10/2023
Location: Virtual
Subject: Oncologic Drug Shortages
FDA Participant/Group: HILARY MARSTON; ANDREW ZACHER;
Non FDA Participant/Group: Government and several National Cancer Institute Designated Cancer Centers
Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner
No Significant Event
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist
Event Date: 08/10/2023
Location: Silver Spring, MD
Subject: FDA Annual Student Scientific Research Day 2023; Keynote Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Staff, students, and stakeholders
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 08/10/2023
Location: Washington, DC
Subject: National Science Foundation Cellular Biomanufacturing 2023 Workshop; Panelist: Complex Regulatory Landscape Surrounding the Translation of Cellular Biomanufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, regulatory, and academic stakeholders
Event Date: 08/10/2023
Location: Washington, DC
Subject: National Science Foundation Cellular Biomanufacturing 2023 Workshop; Keynote Presentation: Regulatory Considerations for Cellular Biomanufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, regulatory, and academic stakeholders
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition
Event Date: 08/08/2023
Location: Virtual
Subject: Continuing Concerns with the FY 2019-2023 Frozen Berry Sampling Assignment and Analytical Method, Retailer(s) Adoption of Enteric Viruses
FDA Participant/Group: KRISTINE BUTLER; TIMOTHY JACKSON; DOUGLAS STEARN; KARI BARRETT; DOUGLAS TICKER;
Non FDA Participant/Group: Donna Garren, Sanjay Gummalla (American Frozen Food Institution); Elizabeth Fawell (Hogan, Lovells, LLP); Lee-Ann Jaykus (North Carolina State University);
Event Date: 08/11/2023
Location: Virtual
Subject: Standards of Identity for Yogurt
FDA Participant/Group: ELIZABETH BRICZINSKI; NICHOLAS ALEXANDER;
Non FDA Participant/Group: Jennifer Trodden (New York State Department of Agriculture);
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
Event Date: 08/11/2023
Location: Virtual
Subject: Update on Truth Initiative’s Activities
FDA Participant/Group: N/A
Non FDA Participant/Group: Robin Koval (Truth Initiative);
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event